Home > News > IATIA score US nanotechnology contract
June 22nd, 2004
IATIA score US nanotechnology contract
Abstract:
The directors of IATIA Limited (IAT) today advised shareholders that the group has entered the field of nano-biotechnology with a US$20,000 research contract from the US based Xradia Inc. The Californian group is planning to use IATIA’s QPI phase retrieval technique to image the bone structure and soft tissues of the mice, which are used various medical experiments including the study of cancer tumour growth and treatment.
Source:
egoli
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013